<?xml version="1.0" encoding="UTF-8"?>
<ref id="B84-molecules-25-05017">
 <label>84.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Perrin-Cocon</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Aublin-Gex</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Sestito</surname>
    <given-names>S.E.</given-names>
   </name>
   <name>
    <surname>Shirey</surname>
    <given-names>K.A.</given-names>
   </name>
   <name>
    <surname>Patel</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Andre</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Blanco</surname>
    <given-names>J.C.</given-names>
   </name>
   <name>
    <surname>Vogel</surname>
    <given-names>S.N.</given-names>
   </name>
   <name>
    <surname>Peri</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Lotteau</surname>
    <given-names>V.</given-names>
   </name>
  </person-group>
  <article-title>TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection</article-title>
  <source>Sci. Rep.</source>
  <year>2017</year>
  <volume>7</volume>
  <fpage>40791</fpage>
  <pub-id pub-id-type="doi">10.1038/srep40791</pub-id>
  <pub-id pub-id-type="pmid">28106157</pub-id>
 </element-citation>
</ref>
